Keyphrases
Pediatric Soft Tissue Sarcomas
100%
Rhabdomyosarcoma
100%
Clinical Trials
100%
Radiotherapy
33%
Soft Tissue Sarcoma
16%
18F-FDG PET-CT
16%
Quality of Life
16%
Biological Risk
16%
Novel Regimens
16%
Imaging Modalities
16%
Imaging Studies
16%
Prognostic Impact
16%
Prognostic Groups
16%
Ultra-high Risk
16%
Result Dissemination
16%
Risk Stratification
16%
Multi-stage Design
16%
Chemotherapy
16%
Poor Prognostic
16%
Local Control
16%
Diffusion Magnetic Resonance Imaging (dMRI)
16%
Maintenance Chemotherapy
16%
MRI Imaging
16%
High-risk Disease
16%
Optimal Duration
16%
Biological Studies
16%
International Collaboration
16%
Prognostic Marker
16%
Metastatic Disease
16%
Medicine and Dentistry
Rhabdomyosarcoma
100%
Soft Tissue Sarcoma
100%
Clinical Trial
100%
Pediatrics
100%
Radiation Therapy
33%
Maintenance Chemotherapy
16%
Risk Stratification
16%
Positron Emission Tomography-Computed Tomography
16%
Fluorodeoxyglucose F 18
16%
Quality of Life
16%
Metastatic Carcinoma
16%
Diffusion MRI
16%
Diseases
16%